PT3737470T - Derivados do ácido 3-fenil-4-hexinoico como agonistas de gpr40 - Google Patents

Derivados do ácido 3-fenil-4-hexinoico como agonistas de gpr40

Info

Publication number
PT3737470T
PT3737470T PT197010291T PT19701029T PT3737470T PT 3737470 T PT3737470 T PT 3737470T PT 197010291 T PT197010291 T PT 197010291T PT 19701029 T PT19701029 T PT 19701029T PT 3737470 T PT3737470 T PT 3737470T
Authority
PT
Portugal
Prior art keywords
phenyl
acid derivatives
hexynoic acid
gpr40 agonists
gpr40
Prior art date
Application number
PT197010291T
Other languages
English (en)
Original Assignee
Celon Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PL424227A external-priority patent/PL233938B1/pl
Application filed by Celon Pharma Sa filed Critical Celon Pharma Sa
Publication of PT3737470T publication Critical patent/PT3737470T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/42Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C07C57/60Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
PT197010291T 2018-01-08 2019-01-07 Derivados do ácido 3-fenil-4-hexinoico como agonistas de gpr40 PT3737470T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL424227A PL233938B1 (pl) 2018-01-08 2018-01-08 Pochodne kwasu 3-fenylo-4-heksynowego jako agoniści GPR40
PL42562518 2018-05-18

Publications (1)

Publication Number Publication Date
PT3737470T true PT3737470T (pt) 2023-03-02

Family

ID=67144423

Family Applications (1)

Application Number Title Priority Date Filing Date
PT197010291T PT3737470T (pt) 2018-01-08 2019-01-07 Derivados do ácido 3-fenil-4-hexinoico como agonistas de gpr40

Country Status (15)

Country Link
US (1) US11964938B2 (pt)
EP (1) EP3737470B9 (pt)
JP (1) JP7289305B2 (pt)
KR (1) KR20200108318A (pt)
CN (1) CN111757770B (pt)
AU (1) AU2019205093B2 (pt)
BR (1) BR112020013694A2 (pt)
CA (1) CA3087712A1 (pt)
DK (1) DK3737470T3 (pt)
ES (1) ES2939720T3 (pt)
FI (1) FI3737470T3 (pt)
MX (1) MX2020007283A (pt)
PL (1) PL3737470T3 (pt)
PT (1) PT3737470T (pt)
WO (1) WO2019134984A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021071837A1 (en) 2019-10-07 2021-04-15 Kallyope, Inc. Gpr119 agonists
CA3178994A1 (en) 2020-05-19 2021-11-25 Iyassu Sebhat Ampk activators
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003277576A1 (en) 2002-11-08 2004-06-07 Takeda Pharmaceutical Company Limited Receptor function controlling agent
EP1630152A4 (en) 2003-05-30 2009-09-23 Takeda Pharmaceutical CONNECTION WITH CONDENSED RING
BRPI0418148A (pt) 2003-12-25 2007-04-17 Takeda Pharmaceutical composto, prodroga de um composto, modulador da função do receptor gpr40, agente farmacêutico, uso de um composto e métodos de modificação de uma função do receptor gpr40 em um mamìfero, de profilaxia ou tratamento de diabetes em um mamìfero e de produção de um composto
BRPI0508098A (pt) 2004-02-27 2007-07-17 Amgen Inc compostos, composições farmacêuticas e métodos para uso no tratamento de distúrbios metabólicos
JP4875978B2 (ja) 2004-03-15 2012-02-15 武田薬品工業株式会社 アミノフェニルプロパン酸誘導体
ES2428538T3 (es) 2004-05-28 2013-11-08 Eli Lilly And Company Antagonistas del receptor de glucagón, preparación y usos terapéuticos
EP1924546A1 (en) 2005-09-14 2008-05-28 Amgen, Inc Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
RS52307B (en) 2006-06-27 2012-12-31 Takeda Pharmaceutical Company Limited CONDENSED CYCLIC UNITS
US7714008B2 (en) 2006-09-07 2010-05-11 Amgen Inc. Heterocyclic GPR40 modulators
US7750048B2 (en) 2006-11-15 2010-07-06 Janssen Pharmaceutica Nv GPR40 agonists
WO2008130514A1 (en) 2007-04-16 2008-10-30 Amgen Inc. Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators
EP2440541A1 (en) 2009-06-09 2012-04-18 Takeda Pharmaceutical Company Limited Novel fused cyclic compound and use thereof
AR078522A1 (es) 2009-10-15 2011-11-16 Lilly Co Eli Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
MA34474B1 (fr) 2010-07-23 2013-08-01 Connexios Life Sciences Pvt Ltd Agonistes de gpr40
EP2694465A4 (en) 2011-04-08 2015-03-18 Univ Syddansk SUBSTITUTED ORTHOFLUOR COMPOUNDS FOR THE TREATMENT OF METABOLISM DISEASES
AR087451A1 (es) 2011-08-17 2014-03-26 Lilly Co Eli Derivado de 1,2,3,4-tetrahidroquinolina util para tratamiento de diabetes
US9238639B2 (en) 2012-02-24 2016-01-19 Takeda Pharmaceutical Company Limited Aromatic ring compound
WO2013128378A1 (en) 2012-02-28 2013-09-06 Piramal Enterprises Limited Phenyl alkanoic acid derivatives as gpr agonists
BR112016013874A2 (pt) 2014-01-10 2017-08-08 Lilly Co Eli Fenil-triazolo-piridina, seus usos, seus processo de produção e seus intermediários, e composição farmacêutica
CN111423408A (zh) * 2014-10-17 2020-07-17 现代药品株式会社 代谢性疾病的预防或治疗用复合制剂

Also Published As

Publication number Publication date
CN111757770A (zh) 2020-10-09
PL3737470T3 (pl) 2023-05-08
MX2020007283A (es) 2020-09-10
AU2019205093B2 (en) 2024-03-07
EP3737470B1 (en) 2022-12-14
CN111757770B (zh) 2023-10-03
BR112020013694A2 (pt) 2020-12-01
US20200399198A1 (en) 2020-12-24
US11964938B2 (en) 2024-04-23
CA3087712A1 (en) 2019-07-11
EP3737470B9 (en) 2024-05-15
AU2019205093A1 (en) 2020-07-16
ES2939720T3 (es) 2023-04-26
JP2021509909A (ja) 2021-04-08
FI3737470T3 (fi) 2023-03-19
EP3737470A1 (en) 2020-11-18
WO2019134984A1 (en) 2019-07-11
JP7289305B2 (ja) 2023-06-09
KR20200108318A (ko) 2020-09-17
DK3737470T3 (da) 2023-03-13

Similar Documents

Publication Publication Date Title
ZA201700629B (en) Substituted phenyl alkanoic acid compounds as gpr120 agonists and uses thereof
HK1253322A1 (zh) 作為hdac抑制劑的3-烷基-4-酰氨基-雙環[4,5,0]異羥肟酸
IL256265B (en) 3-tetrazolyl-benzene-2,1-disulfonamide derivatives as metallo-beta-lactamase inhibitors
ZA201703112B (en) Substituted benzothiophenyl derivatives as gpr40 agonists for the treatment of type ii diabetes
ZA201604527B (en) Compounds for use as gpr120 agonists
EP3587576A4 (en) ANTI-SENSE OLIGONUCLEIC ACID
IL252882B (en) History of benzoic acid bicycloheteroaryl-heteroaryls as beta-retinoic acid receptor agonists
SG11202100727VA (en) Boronic acid derivatives
IL278933A (en) TLR7 agonists
ZA201905379B (en) 1-amino-1-cyclopropanecaboxylic acid formulations
PT3737470T (pt) Derivados do ácido 3-fenil-4-hexinoico como agonistas de gpr40
PL3672977T3 (pl) Pochodne kwasu boronowego
EP3976576A4 (en) Gpr40 agonists
EP3253745A4 (en) Compounds containing carbon-carbon linker as gpr120 agonists
EP3774951C0 (en) BORONIC ACID DERIVATIVES FOR DIOLS DETECTION HYDROGELS
SG11202003286YA (en) Cool-sensation imparter composition containing 2,2,6-trimethylcyclohexanecarboxylic acid derivative
EP3166405A4 (en) 3'-substituted-abscisic acid derivatives
EP3894434A4 (en) ERYTHROPOIETIN ANALOGS FOR VETERINARY USE
EP3121188A4 (en) Crystalline 3',5'-cyclic diguanylic acid
EP3372578A4 (en) NOVEL CITRIC ACID DERIVATIVE
EP3279184A4 (en) Novel benzoic acid amide compound
EP4043565A4 (en) MODIFIED HETERONUCLEIC ACID
EP4062976A4 (en) CARBALYSOPHOSPHATIDIC ACID
EP3658527A4 (en) ACRYLIC ACID ANALOGUES